Stock Groups

U.S. administers 382.3 million doses of COVID-19 vaccines

[ad_1]

© Reuters. FILE PHOTO: Yomaria de Santiago (35), a student at Cal State Dominguez Hills, is given a Pfizer BioNTech coronavirus vaccine (19COVID-19) in Carson, Los Angeles. This was on August 26, 2021. REUTERS/Lucy Nicholson

The United States has administered 382,294,795 doses of COVID-19 vaccines in the country as of Wednesday morning and distributed 461,117,525 doses, the U.S. Centers for Disease Control and Prevention said.

These figures surpass the 381,453,265 vaccination doses that the CDC reported had been administered by September 14th, out of the 458,771,465 total doses.

According to the agency, 210,361,099 individuals had already received at least one vaccine dose, while 179,695,287 were fully vaccinated by 6:00 AM. ET on Wednesday.

The CDC tally includes two-dose vaccines from Moderna (NASDAQ:) and Pfizer/BioNTech, as well as Johnson & Johnson (NYSE:)’s one-shot vaccine.

Over 1.9 million people received an additional dose of either Pfizer (NYSE:) or Moderna’s vaccine since Aug. 13, when the U.S. authorized a third dose of the vaccines for people with compromised immune systems who are likely to have weaker protection from the two-dose regimens.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by exchanges. Instead, they are determined by marketmakers. As such, the prices might not reflect market conditions and could be incorrect. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.



[ad_2]